Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation.
Bornhauser
M
M
Thiede
C
C
Babatz
J
J
Schetelig
J
J
Illmer
T
T
Kiani
A
A
Platzbecker
U
U
Herr
W
W
Rieber
E-P
EP
Ehninger
G
G
Schmitz
M
M
D019264:Adoptive Transfer / Q000379:methods*; D000328:Adult; D018952:Antigens, CD34 / Q000378:metabolism; D003713:Dendritic Cells / Q000378:metabolism; D016044:Fusion Proteins, bcr-abl; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000628:therapy*; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism / Q000627:therapeutic use; D012074:Remission Induction; D013601:T-Lymphocytes / Q000378:metabolism / Q000637:transplantation*; D014184:Transplantation, Homologous
D018952:Antigens, CD34; D010446:Peptide Fragments; D016044:Fusion Proteins, bcr-abl